35 completed, 5 unknown, 3 recruiting, 3 terminated. 49 Phase 2, 10 Phase 3, 8 Phase 1.
Follow Abdominal Pain: new trials by email Literature Review of Abdominal Pain trials Research Report on Abdominal Pain
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Soy Tomato Juice to Improve Outcomes in Pancreatitis Soy-tomato juice product, Will include a soy-tomato juice product to be consumed during the 4 week intervention phase. A total of about 12 ounces (administered in two small cans) of the juice will be consumed - Recurrent Acute Pancreatitis, Chronic Pancreatitis | Phase 1 / Phase 2 | Recruiting | Ohio State University | 35 | 2026-04-02 | 2026-10-20 |
| Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis Rifaximin 550 MG Oral Tablet [XIFAXAN], Placebo - Cystic Fibrosis, Abdominal Pain | Phase 2 / Phase 3 | Withdrawn | Wake Forest University Health Sciences | 2025-07-01 | 2025-06-27 | |
| Acupuncture Versus Compound Diclofenac Sodium for Pain Relief in Non-Traumatic Acute Abdominal acupuncture, compound diclofenac sodium, acupuncture combined with compound diclofenac sodium - Acute Abdominal Pain, Acupuncture Therapy | Phase 1 / Phase 2 | Not yet recruiting | The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine | 176 | 2025-06-01 | 2025-05-21 |
| Treatment of Moderate to Severe Refractory Crohn's Disease TRX103, Cyclophosphamide - Crohns Disease | Phase 1 / Phase 2 | Recruiting | Tr1X, Inc. | 39 | 2025-05-05 | 2025-12-10 |
| Psyllium in Pediatric IBS Psyllium (0.7 g/year of age per day), Psyllium (0.5 g/year of age per day), Placebo - Irritable Bowel Syndrome | Phase 2 | Recruiting | Dr Bruno Chumpitazi, M.D. | 110 | 2025-02-20 | 2026-05-26 |
| A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis. CIN-102 Dose 15mg, Placebo, CIN-102 Dose 10mg - Idiopathic Gastroparesis | Phase 2 | Completed | CinDome Pharma, Inc. | 416 | 2025-01-29 | 2026-07-13 |
| Study of Hesperidin Therapy on COVID-19 Symptoms (HESPERIDIN) Hesperidin, Placebo - Covid19, Anosmia | Phase 2 | Completed | Montreal Heart Institute | 216 | 2021-02-18 | 2022-04-08 |
| Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome 3mg AZ-010, 1mg AZ010, Staccato Placebo - Cyclic Vomiting Syndrome | Phase 2 | Completed | Alexza Pharmaceuticals, Inc. | 150 | 2021-02-05 | 2025-06-11 |
| Efficacy and Safety of Oral OPS-2071 in Participants With Crohn's Disease Showing Symptoms of Active Inflammation OPS-2071, Placebo - Crohn's Disease | Phase 2 | Terminated | Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | 2020-02-25 | 2021-06-15 |
| Olorinab in Irritable Bowel Syndrome With Predominant Constipation (IBS-C) and Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D) Olorinab, Placebo - Irritable Bowel Syndrome | Phase 2 | Terminated | Arena Pharmaceuticals | 273 | 2019-07-24 | 2025-01-30 |
| A Study of MD-7246 to Treat Abdominal Pain in Patients With Diarrhea-predominant Irritable Bowel Syndrome MD-7246, Placebo - Irritable Bowel Syndrome With Diarrhea (IBS-D) | Phase 2 | Completed | Ironwood Pharmaceuticals, Inc. | 515 | 2019-05-01 | 2021-03-12 |
| Tolerability, Pharmacokinetics, and Efficacy of APD371 in Participants With Crohn's Disease Experiencing Abdominal Pain Olorinab - Crohn's Disease, Abdominal Pain | Phase 2 | Completed | Arena Pharmaceuticals | 14 | 2017-07-19 | 2021-11-02 |
| Analgesic Efficacy of Dexmedetomidine Added to Fentanyl in PCEA TEA+DEX, TEA - Abdominal Pain, Abdominal Cancer | Phase 2 / Phase 3 | Completed | South Egypt Cancer Institute | 90 | 2017-06-30 | 2020-03-23 |
| The Probiotic Study: Using Bacteria to Calm Your Mind Lactobacillus rhamnosus - Anxiety, Abdominal Pain | Phase 2 | Completed | Nancy Zucker | 9 | 2016-11-08 | 2026-06-10 |
| Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis KHK4083, Placebo - Ulcerative Colitis, Digestive System Diseases | Phase 2 | Completed | Kyowa Kirin, Inc. | 66 | 2016-06-01 | 2024-04-26 |
| Evaluation of the Effect of a Probiotic Supplement Upon Gastrointestinal Function Probiotic mix CBP-004019/C, Placebo - Signs and Symptoms, Digestive, Dyspepsia | Phase 1 / Phase 2 | Unknown | Biopolis S.L. | 60 | 2016-06-01 | 2016-10-10 |
| Bifidobacterium Infantis M-63 Improves Mental Health in Irritable Bowel Syndrome Developed After a Major Flood Disaster Probiotics M-63, Control group - Irritable Bowel Syndrome, Abdominal Pain | Phase 2 / Phase 3 | Completed | Universiti Sains Malaysia | 53 | 2015-09-01 | 2017-10-24 |
| Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study Menthae piperitae aetheroleum/peppermint oil (enteric coated capsule), Menthae piperitae aetheroleum/peppermint oil (colon-targeted-delivery capsule) - Irritable Bowel Syndrome, Abdominal Pain | Phase 2 | Completed | Maastricht University Medical Center | 8 | 2015-03-01 | 2022-01-24 |
| Probiotic Supplementation Among Adults With Recurrent Gastrointestinal Symptoms Probiotic dietary supplement (Trenev Trio®), placebo - Gastrointestinal Symptoms, Bloating | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 80 | 2014-12-01 | 2021-09-14 |
| Treatment of Suspected Cholelithiasis With Nitroglycerin sublingual nitroglycerine - COLIC, BILIARY TRACT DISEASES | Phase 2 | Unknown | United States Naval Medical Center, San Diego | 62 | 2014-10-01 | 2017-09-29 |
Showing 20 of 49. Sign in to see all of them.
Irritable Bowel Syndrome (14) · Diarrhea (10) · Nausea (5) · Chronic Pain (4) · Gastrointestinal Diseases (4) · Vomiting (4) · Colonic Diseases (3) · Constipation (3) · Crohn Disease (3) · Dyspepsia (3) · Headache (3) · Pancreatitis, Chronic (3) · Visceral Pain (3) · Abdomen, Acute (2)
Neurologic Manifestations (49) · Pathological Conditions, Signs and Symptoms (49) · Signs and Symptoms (49) · Pain (47) · Signs and Symptoms, Digestive (47) · Digestive System Diseases (27) · Gastrointestinal Diseases (18) · Intestinal Diseases (17) · Colonic Diseases, Functional (14) · Colonic Diseases (13) · Pathologic Processes (7) · Gastroenteritis (5) · Pancreatic Diseases (5) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Chronic Disease (3)
Dronabinol (3) · Acupuncture Therapy (2) · Cognitive Behavioral Therapy (2) · olorinab (2) · 12,13-dihydro-N-methyl-6,11,13-trioxo-5H-benzo(4,5)cyclohepta(1,2-b)naphthalen-5,12-imine (1) · Acetylglucosamine (1) · Amitriptyline (1) · Bisacodyl (1) · Bupivacaine (1) · Citalopram (1) · Control Groups (1) · Cyclophosphamide (1) · Diazepam (1) · Elimination Diets (1) · Escitalopram (1)
Mayo Clinic (3) · Radboud University Medical Center (3) · Arena Pharmaceuticals (2) · Bausch Health Americas, Inc. (2) · Seattle Children's Hospital (2) · Alexza Pharmaceuticals, Inc. (1) · Azienda Ospedaliero-Universitaria di Modena (1) · Baylor College of Medicine (1) · Biopolis S.L. (1) · Boehringer Ingelheim (1) · CinDome Pharma, Inc. (1) · Dr Bruno Chumpitazi, M.D. (1) · Erasme University Hospital (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · IWK Health Centre (1)
United States (29) · Netherlands (4) · Canada (3) · Italy (3) · Poland (2) · Romania (2) · Belgium (1) · China (1) · Czechia (1) · Egypt (1) · Germany (1) · Hungary (1) · Ireland (1) · Lithuania (1) · Russia (1)
Arena CT.gov Administrator (2) · Harry van Goor, MD PhD (2) · A Masclee, Prof, PhD, MD (1) · Alaa M. Elzohry, MD (1) · Baha Moshiree, MD (1) · Bincy P Abraham, M.D., M.S. (1) · Brian E. Lacy, M.D., Ph.D. (1) · Bruno Chumpitazi, MD, MPH (1) · Charlene M Prather, M.D. (1) · Chris D'Adamo, PhD (1) · Colin P Howden, M.D. (1) · Earnest P Bouras, M.D. (1) · G. R. Locke, III, M.D. (1)
PMID 27720917, PMID 19148734, PMID 19695776, PMID 22343090, PMID 22511033, PMID 22773240, PMID 23277304, PMID 24796768, PMID 25761431, PMID 25775441, PMID 25921377, PMID 26166166, PMID 27080737, PMID 27269295, PMID 27474763, PMID 29199141, PMID 29578090, PMID 30284674, PMID 30525951, PMID 33433147, PMID 33863856, PMID 34854473, PMID 36740814, PMID 38123024, PMID 39356039
2008 (1), 2014 (1), 2019 (1), R01DK138871 (1), R01MH069715 (1), R01NR005337 (1), U01DK065713 (1), UL1RR024150 (1)